Search

everythinglearnresearchcommunity

for

Search:↓

The analysis shows the U.S. leads in tissue expansion research, mainly for breast reconstruction, with a slightly higher complication rate when using acellular dermal matrix.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Microsponges delivery system is a safe, versatile method for controlled drug release in various treatments.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Mesotherapy is more effective than topical spray for female hair loss treatment.

Using bioreactors, scientists can grow more skin stem cells that keep their ability to regenerate skin and hair.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Combining fire needle therapy with doxycycline improves severe acne more than doxycycline alone.

Sandalore®, a synthetic scent, improved hair loss and satisfaction in women with telogen effluvium.

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

PRP injections promote hair growth and increase hair density in androgenic alopecia.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Low-dose radiation therapy may improve brain function in some Alzheimer's patients and is generally well-tolerated.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

A new skin treatment using a patient's own cells healed chronic wounds effectively and was preferred over traditional grafts.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

The study found that expanded skin regenerates similarly to normal skin, with 77 genes playing a role in the process.

Using a protocol with LH improves pregnancy rates in patients with low ovarian reserve.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

The treatment using a special hydrogel shows promise for promoting hair growth.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Certain small molecules can promote hair growth by activating a cellular cleanup process called autophagy.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Platelet lysate effectively promotes hair growth and improves hair thickness in people with androgenetic alopecia.

As of 1994, treatments for liver cancer had not significantly improved patient survival.